Hoechst AG produced specialty chemicals and pharmaceutical products. It products ranged in areas of heart cycle, thrombose, central nervous system, onkologie, diabetes, metabolic illnesses, internal medicine and vaccines. Founded in 1863, the company was headquartered in Frankfurt am Main, Germany.

Merial, Inc. develops pharmaceutical products and vaccines for pets and wildlife. It provides healthcare products and food for dogs, cats, cattle, horse, and poultry producers. The company was founded in August 1997 and is headquartered in Duluth, GA.

Novartis Animal Health is a leader in developing new and better ways to prevent and treat diseases in pets, farm animals and farmed fish. Their innovative, high-quality medicines contribute to the quality of life, health and welfare of animals around the world. They focus on developing new products and technologies to meet the diverse needs of pet owners, veterinarians, farmers and fish farmers now and in the future. Their scientists strive to improve animal care and welfare by researching new medicines and novel drug delivery technologies to improve efficacy and ease of use.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Kenilworth, NJ.

Ciba-Geigy AG was manufacturing pharmaceuticals. The company was merged with Sandoz Ltd. to create Novartis AG. The company was founded in 1884 and was headquartered in Basle, Switzerland.

Engages in priniting activities

Part of Wuthelam Holdings Ltd., Dulux Australia Ltd. is a company headquartered in Scoresby, Australia, focused on household furniture.

Instytut Chemii Bioorganicznej Pan (doing business as Institute of Bioorganic Chemistry) is a Polish company ultimately controlled by the Government of Poland. The firm operates as a physical-chemical biology and biotechnology center.

BTG acquires, develops, manufactures, and commercializes pharmaceutical products in the United States, Europe, and internationally. It operates through three segments: Interventional Medicine, Pharmaceuticals, and Licensing. The Interventional Medicine segment offers interventional oncology products and systems, such as beads and TheraSphere for treatment of liver cancer; and GALIL medical system, a cryoablation technology for use in kidney cancer and other indications. This segment also provides interventional vascular products consisting of EKOS system, an ultrasonic catheter drug delivery device used in the treatment of blood clots; Varithena for the treatment of varicose veins; and PneumRx Coil for the treatment of emphysema, a debilitating lung disease. The Pharmaceuticals segment offers antidote products, such as CroFab for the treatment of crotalid snake envenomations; DigiFab for the treatment of digoxin toxicity; and Voraxaze for high-dose methotrexate toxicity. The Licensing segment provides Zytiga for treatment of prostate cancer; Two-Part Hip Cup; and Lemtrada. The company also manufactures and commercializes therapeutic ultrasound devices, and roxwood systems, as well as develops venous thrombus management devices. British Technology Group International that began operation in 1948 became BTG in March 1995. Its headquarters is in London in the United Kingdom.

Shenzhen Huakang Biomedical Engineering Co., Ltd., established on 1992-06-26, Business scope includes general business items:biotechnology development,technology transfer,Technical Consulting and Technical Services(None of the above items involve special management measures for foreign investment access,involved in state trade,quota,Permits and special management regulations,According to the relevant regulations of the state to apply for operation).,The licensing program is:Production and operation of in vitro diagnostic reagents,Medical device products(Class I,Class II,Class III),Experimental Reagent Consumables,Healthy food;Biochemical reagents,biopharmaceutical products,Medical device products(Class I,Class II,Class III)and health food import and export business(None of the above items involve special management measures for foreign investment access,involved in state trade,quota,Permits and special management regulations,According to the relevant regulations of the state to apply for operation).

Bayer AG engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials. It operates through the following segments: Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro. The Pharmaceuticals segment engages in the development, production and marketing of prescription products for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology and ophthalmology; diagnostic imaging equipment and the necessary contrast agents. The Consumer Health segment manufactures and markets products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories. The CropScience segment includes seeds and plant traits, crop protection and nonagricultural pest control. The Animal Health segment offers prescription and nonprescription veterinary products. The Covestro segment provides raw materials for polyurethanes; polycarbonate granules and sheets; raw materials for coatings, adhesives and sealants; and by-products of polyether production and of chlorine production and use. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.

Develops and manufactures natural food additives, veterinary vaccines and pharmaceuticals

Elanco U.S., Inc. develops products and services that enhance animal health, wellness, and performance. The company was founded on December 16, 1996 and is headquartered in Greenfield, IN.

Merial SAS develops, manufactures, and distributes pharmaceutical products and vaccines for animals. It provides therapeutic medicines that treat the diseases of dogs, cats, chickens, cows, pigs, and horses. The company was founded in 1997 and is headquartered in Treillieres, France.

Shenzhen Kangbaide Biotechnology Co., Ltd., established on 2003-06-05, Business scope includes general business items:bioassay technology,Development of proteomics technology;Biotechnology Consulting and Services;Sales of experimental equipment and consumables(No restricted items);Domestic Trade;Operating import and export business.(All of the above are in accordance with the law,Administrative regulations,Decisions of the State Council and other regulations that require approval,Can only operate after obtaining relevant approval documents according to law),The licensing program is:Production of biotechnological products(Does not contain pharmaceutical production,sales law,Items restricted by administrative regulations);veterinary medicine,Veterinary Disinfectant,Sales of veterinary biological products not required by the national compulsory immunization plan.